These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2499540)

  • 1. Effect of chemical modification of histidine and tyrosine residues in toxic shock syndrome toxin 1 on the serologic and mitogenic activities of the toxin.
    Kokan-Moore NP; Bergdoll MS
    Infect Immun; 1989 Jul; 57(7):1901-5. PubMed ID: 2499540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
    Bonventre PF; Heeg H; Cullen C; Lian CJ
    Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of biologically active region in toxic shock syndrome toxin 1.
    Kokan-Moore NP; Bergdoll MS
    Rev Infect Dis; 1989; 11 Suppl 1():S125-9. PubMed ID: 2467343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody.
    Blanco L; Choi EM; Connolly K; Thompson MR; Bonventre PF
    Infect Immun; 1990 Sep; 58(9):3020-8. PubMed ID: 1696937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
    Bonventre PF; Heeg H; Edwards CK; Cullen CM
    Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells.
    Drynda A; König B; Bonventre PF; König W
    Infect Immun; 1995 Mar; 63(3):1095-101. PubMed ID: 7532624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments.
    Blomster-Hautamaa DA; Novick RP; Schlievert PM
    J Immunol; 1986 Dec; 137(11):3572-6. PubMed ID: 3782792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of monoclonal antibodies to toxic shock syndrome toxin 1 and use of a monoclonal antibody in a rapid, one-step enzyme-linked immunosorbent assay for detection of picogram quantities of toxic shock syndrome toxin 1.
    Wells DE; Reeves MW; McKinney RM; Graves LM; Olsvik O; Bergan T; Feeley JC
    J Clin Microbiol; 1987 Mar; 25(3):516-21. PubMed ID: 3106406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
    Feng MH; Cui JC; Nakane A; Hu DL
    Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.
    Bonventre PF; Thompson MR; Adinolfi LE; Gillis ZA; Parsonnet J
    Infect Immun; 1988 Jan; 56(1):135-41. PubMed ID: 3257201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of functional antigenic segments of toxic shock syndrome toxin 1 by differential immunoreactivity and by differential mitogenic responses of human peripheral blood mononuclear cells, using active toxin fragments.
    Edwin C; Kass EH
    Infect Immun; 1989 Jul; 57(7):2230-6. PubMed ID: 2731989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome.
    Gampfer J; Thon V; Gulle H; Wolf HM; Eibl MM
    Vaccine; 2002 Jan; 20(9-10):1354-64. PubMed ID: 11818153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogenic properties of two distinct forms of toxic shock syndrome toxin-1 separated on hydroxyapatite by high-performance liquid chromatography.
    Naidu AS; Eriksson KO; Hallberg T; Lindeberg J; Liao JL; Yao K; Wadström T; Hjertén S
    APMIS; 1989 Dec; 97(12):1088-96. PubMed ID: 2558692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bindings of toxic shock syndrome toxin-1 and staphylococcal enterotoxins A, B, and C to rabbit spleen cells.
    Fujikawa H; Takayama H; Uchiyama T; Igarashi H
    Microbiol Immunol; 1989; 33(5):381-90. PubMed ID: 2755362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis.
    Hofer MF; Lester MR; Schlievert PM; Leung DY
    Clin Exp Allergy; 1995 Dec; 25(12):1218-27. PubMed ID: 8821303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody.
    Pang LT; Kum WW; Chow AW
    Infect Immun; 2000 Jun; 68(6):3261-8. PubMed ID: 10816471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
    Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
    J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin.
    Uchiyama T; Kamagata Y; Wakai M; Yoshioka M; Fujikawa H; Igarashi H
    Microbiol Immunol; 1986; 30(5):469-83. PubMed ID: 3489157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of in vitro proliferation of human T cells by a synthetic peptide of toxic shock syndrome toxin 1.
    Edwin C; Swack JA; Williams K; Bonventre PF; Kass EH
    J Infect Dis; 1991 Mar; 163(3):524-9. PubMed ID: 1995725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.